1Kawana K, Yasug/T, Taketani Y. Human papi|lomavirus vaccines: current issues and future[J]. Indian J Med Res, 2009, 130(3) : 341 - 347.
2Bosch FX, Sanjose SD, Castellsague X. HPV and genital cancer. The essential epidemlology [ M ]. New York : Oxford University Press Inc, 2008 : 35 -48.
4Smith JS, Lindsay L, Hoots B, et al. HPV type distribution in invasive cervical cancer and high - grade cervical lesions : A meta - analyses update[J]. IJC , 2007, 121(3) : 621 -632.
9Block SL, Brown DR, Chatterjee A, et al. Clinical trial and post- licensure safety profile of a prophylactic human papillomavirus ( types6.11.16andl8 ) 11 Virus - like particle vaccine[ J]. Pediatr Infect Dis J, 2010, 29(2) :95 -101.
2zur Hausen H. Papilloma virus and cancer: from basic studies to clinical application. Nat Rev Cancer, 2002, 2:342-350.
3Cuzick J, Clavel C, Petry KU, et al. Overview of the European and North American studies on HPV testing in primary cervical cancer screening. Int J Cancer 2006,119 : 1095-1101.
4Lo KW, Wong YF, Chan MK, et al. Prevalence of human papillomavirus in cervical cancer: a multicenter study in China. Int J Cancer,2002,100:327-331.
5Bosch FX, Sanjose SD, Castellsague X. HPV and genital cancer: the essential epidemiology [ M]. New York: Oxford University Press Inc,2008:35-48.
6Smith JS, Lindsay L, Hoots B, et al. Human papilloma virus type distridution in vasive cervical cancer and high- grade cervical lesions [ J ]. Int J Cancer, 2007,121 (6) : 621-632.
7Duensing S, Mungen K. Mechanisms of genomic instability in human cancer : insights from study with human papiloma virus oncoproteins [ J ]. Int J Cancer,2004,109 (9) : 157-162.
8Brabin L, Roberts SA, Farzanch F, et al. Future acceptance of adolescent human papilloma virus vaccination [ J ]. Vaccine, 2006,24 ( 9 ) : 3087-3094.
9Kawana K, Yasugi T, Taketani Y. Human papillomavirus vaccines : current issues & future [ J ]. Indian J Med Res, 2009,130(3) :341-347.
10Cid-Arregui A. Therapeutic vaccines against human papillomavirus and cervical cancer [ J ]. Open Virol J, 2009,3( 1 ) :67-83.
8Peltecu G, Bail M, Lancu G, eta]. Human papilloma virus and cervi- ca] preinvasive disease [J]. J Med Life,2009,2(4) :373 -377.
9Gravitt PE, Paul P, Katki HA, et al. Effectiveness of VIA,Pap, and HPV DNA testing in a cervical cancer screening program in a periurban community in Andhra Pradesh, India[ J] . PLoS One, 2010,5 ( 10 ) : 13711.
10Cusehieri KS, Cubie HA, Whitley MW, et al. Multiple high risk HPV infection are common in cervical ncoplasia and young women in a cervical screening populationl[J]. J Clin Pathol,2004,57 ( 1 ) :68 - 72.
